Mid-Atlantic Section of the American Urological Association (MAAUA) Search MA-AUA
Mid-Atlantic Section of the American Urological Association (MAAUA)
Home | About Us | Contact Us   
  Home
  Members
    Members Only Area
    Member Directory
    Join the MA-AUA
  Annual Meeting
  Future Meetings
  Board of Directors
  Committees
  Careers
  Newsletters
  Visit the AUA
  Advocacy Efforts

 
  Members Only
  Username
 
  Password
 
   Forgot Password?

 
 

Back to Scientific Program
Back to Annual Meeting
Identification Of Patients At High Risk Of Prostate Cancer-Specific Mortality After Radical Retropubic Prostatectomy
Matthew Nielsen, Michael Muntener*, Elizabeth Humphreys, Leslie Mangold, Patrick C Walsh, Alan W. Partin
Johns Hopkins, Baltimore, MD

Introduction: We sought to develop a model to identify a cohort of patients at high risk of prostate cancer (CaP)-specific mortality after radical retropubic prostatectomy for clinically localized disease.
Methods: Proportional hazards analysis was applied to a cohort of patients to develop a multifactorial predictive model to identify men with the highest risk of CaP-specific mortality. Patients with organ-confined Gleason 6 disease were excluded as they had 100% CaP specific survival. The modeling cohort therefore included 3258 men, of whom 87 died of prostate cancer. Variables were removed in a stepwise fashion when they failed to explain differences in the risk of CaP-specific mortality
Results: Prostatectomy Gleason score, seminal vesicle invasion and lymph node metastasis were significant independent predictors of CaP-specific mortality on multivariate analysis. A model for weighted risk of CaP-specific mortality was developed based on coefficients of logistic regression: Mr= RRP Gleason score 4+3 (0/1) x 1.4 + RRP Gleason score 8-10 (0/1) x 2.1 + seminal vesicle involvement (0/1) x 0.8 + lymph node involvement (0/1) x 0.86. Kaplan-Meier analyses demonstrated rapid deviation of the curves based on the Mr. Men with an Mr greater than 2.75 demonstrated a 23.6% CaP-specific mortality rate at 10 years, versus 2.8% for those with a value of less than 2.75.
Conclusions: We have developed a Cox proportional hazards model that successfully stratifies patients based upon their risk of CaP-specific mortality. Application of this model should provide information useful for patient selection and the design of trials of adjuvant therapies


Back to Scientific Program
Back to Annual Meeting

 

 
     
     
Copyright © 2010 Mid-Atlantic Section of the American Urological Association. All Rights Reserved.
Read Privacy Policy.